Tasly Pharmaceutical Group Co., Ltd.
A pioneer in the modernization of traditional Chinese medicine, the publicly traded Tasly Pharmaceutical Group Co., Ltd. was founded in 1994 by Yan Xijun and his wife Wu Naifeng in Tianjin, China. The couple who met while training as pharmacists at a military medical school, had developed a new method to extract the active substance from Danshen, or red sage root, an herbal ingredient known to be effective in treating heart diseases. The active substance presented as “dripping pills” became the main product of Tasly, capturing 36% market share of this proprietary Chinese medecine. In 2005, the couple’s son Kaijing joined the company and in 2014 took over from his father Xijun as chairman of Tasly. Xijun had planned and executed his succession with military precision, ensuring that a professional management team was put in place to head the group while he and his wife, the first generation, took their leave as planned.
This case sets the scene for a discussion on succession planning and governance in a publicly traded family business.
Tasly Pharmaceutical, Healthcare, Pharmaceuticals
1994-2014
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
Though little-known outside of its home country of France, the Mulliez family enterprise is one of the largest privately held business networks in the world. The Association Familiale Mulliez (AFM) unites over 1,000 family shareholders and oversee...
Case B of the Mulliez Family Business case series examines the family's entrepreneurial 'DNA': the unique set of characteristics that have enabled the Association Familiale Mulliez (AFM) to successfully nurture the ventures of the next generations...
This article examines the role of businesses and managers in driving sustainable development, with a focus on family firms. Drawing on the mixed gamble perspective, we compare the progress of family and non-family firms toward achieving SDG 7 (aff...
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in Review of Managerial Science April 2026, vol. 20, pp.1387–1417, https://doi.org/10.1007/s11846-025-00960-4
Research Information & Knowledge Hub for additional information on IMD publications